Gorilla and King Portfolio Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cosmo Daisey who wrote (49070)	11/22/2001 9:22:45 PM
From: Seeker of Truth	Read Replies (1) of 54805

The easiest most obvious question about the biotech stocks is where are the profits, but that's not the only point. The technology of each company seems to have an uncertain domination of the marketplace. The impression of biotechnology I get is that each company is selling a tiny piece of the puzzle. The researchers in the labs themselves are so uncertain of the final outcome that they and their venture capitalist backers are typically eager to sell us a good part of their holdings. When such fragmentary technology is finally proven we still have to assess how valuable it is in the whole picture, i.e. how much the big drug companies will be willing to pay for it. Lots of luck. I personally prefer the risks of profitable companies like QCOM,INTC, SEBL etc. ,aka the gorillas of this board. The big picture is that thousands of us amateur investors are being asked or tempted to pay for research that is too expensive and risky for the big drug companies to want to do too much of. So we are encouraged to finance the tiny companies by buying their shares. Overall it looks beneficial to humanity but maybe not to the individual investor.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next